Eduardo Carlos
Salido Ruiz
Catedrático de Universidad
Saray
Díaz Rodríguez
Saray Díaz Rodríguez-rekin lankidetzan egindako argitalpenak (2)
2022
-
In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
Molecular Therapy - Methods and Clinical Development, Vol. 25, pp. 137-146